Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Compass Therapeutics Inc (NASDAQ: CMPX) closed the day trading at $1.38 down -13.21% from the previous closing price of $1.59. In other words, the price has decreased by -$13.21 from its previous closing price. On the day, 1.35 million shares were traded. CMPX stock price reached its highest trading level at $1.62 during the session, while it also had its lowest trading level at $1.34.
Ratios:
For a better understanding of CMPX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 31.84 and its Current Ratio is at 31.84. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on November 15, 2024, Downgraded its rating to Market Perform and sets its target price to $4 from $5 previously.
On September 16, 2024, Ladenburg Thalmann Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
On January 31, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $8.Jefferies initiated its Buy rating on January 31, 2023, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 189872816 and an Enterprise Value of 61348056. For the stock, the TTM Price-to-Sale (P/S) ratio is 193.87 while its Price-to-Book (P/B) ratio in mrq is 1.37. Its current Enterprise Value per Revenue stands at 72.174 whereas that against EBITDA is -1.119.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $2.34, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is -21.34%, while the 200-Day Moving Average is calculated to be -9.34%.
Shares Statistics:
Over the past 3-months, CMPX traded about 456.31K shares per day on average, while over the past 10 days, CMPX traded about 642340 shares per day. A total of 127.67M shares are outstanding, with a floating share count of 85.18M. Insiders hold about 37.59% of the company’s shares, while institutions hold 39.10% stake in the company. Shares short for CMPX as of 1730332800 were 1786958 with a Short Ratio of 3.92, compared to 1727654400 on 2490031. Therefore, it implies a Short% of Shares Outstanding of 1786958 and a Short% of Float of 1.8399999999999999.
